Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Medtronic
Baxter
Express Scripts
Johnson and Johnson

Last Updated: January 21, 2022

DrugPatentWatch Database Preview

Details for Patent: 7,802,568


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,802,568
Title:Cartridge for a liquid
Abstract: For meteredly dispensing a liquid over a period of several months from a container which can be stored over a long period of time, the need is for a container which is practically diffusion-tight and in which the liquid does not come into contact with the ambient atmosphere. The cartridge according to the invention is a three-shell container comprising a collapsible bag which contains the liquid, a container which is stable in respect of shape and a stiff metal casing. The cartridge can be releasably connected to a dispensing device. The cartridge can be provided with a micro-opening with which the time for pressure equalisation between the cartridge and the ambient atmosphere can be adjusted. The cartridge is suitable for aqueous and for alcoholic liquids which contain a pharmaceutically active substance. The liquid in the cartridge is protected from external influences. The cartridge can be used in an atomiser for producing an inhalable aerosol for the treatment of illnesses.
Inventor(s): Eicher; Joachim (Dortmund, DE), Geser; Johannes (Dortmund, DE), Hausmann; Matthias (Dortmund, DE), Schyra; Michael (Wuppertal, DE), Wuttke; Gilbert (Dortmund, DE), Fiol; Andreas (Wuppertal, DE), Kladders; Heinrich (Muelheim, DE), Hochrainer; Dieter (Bingen am Rhein, DE), Zierenberg; Bernd (Bingen am Rhein, DE)
Assignee: Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
Application Number:11/232,896
Patent Claim Types:
see list of patent claims
Device;

Drugs Protected by US Patent 7,802,568

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,802,568

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany199 40 713Feb 23, 1999
MalaysiaPI 99 00627Aug 26, 1999

International Family Members for US Patent 7,802,568

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 022717 ⤷  Try it Free
Austria 277582 ⤷  Try it Free
Australia 3422600 ⤷  Try it Free
Australia 759881 ⤷  Try it Free
Bulgaria 105785 ⤷  Try it Free
Bulgaria 64454 ⤷  Try it Free
Brazil 0008423 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Dow
Mallinckrodt
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.